STAT News

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.

作者 STAT News

1 分钟阅读
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察